Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IN › Muncie › NPI 1497426050
Clinic

Comprehensive Pain and Spine Specialists LLC

Comprehensive Pain and Spine Specialists LLC was paid $811K by Medicaid between Jan 2022 and Nov 2024, across 21 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 61% of everything it billed.

33Billing provider infoCOMPREHENSIVE PAIN AND SPINE SPECIALISTS LLC
MUNCIE, IN 47304
33aNPI1497426050assigned 09/23/2021
33bProvider typePain Clinic/Center
28Total paid$811K
24GClaims24,257
24DCodes billed21
24AFirst – last monthJan 2022 – Nov 2024
Compared with peers

Next to other Pain Clinic/Center providers in Indiana

Rank by total paid#2 of 7
Median peer was paid$36K
This provider vs. median23×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K$60K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20225,403$136K
20239,124$305K
2024incomplete9,730$370K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 61% 15,458 10,451 $491K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 6.7% 821 643 $54K
L0650 Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf 5.9% 111 95 $48K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 5.8% 2,032 1,383 $47K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 5.2% 399 274 $42K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 5.2% 2,175 1,484 $42K
64635 2.2% 140 80 $18K
64493 1.8% 237 167 $15K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 1.1% 217 172 $9K
64494 1.1% 318 165 $9K
62370 1.0% 374 245 $8K
64636 <1% 114 68 $7K
9 more codes
99152 <1% 876 $7K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed <1% 547 $7K
27096 <1% 72 $5K
76942 <1% 85 $850.24
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 68 $597.92
99215 Doctor's office visit, returning patient (complex) <1% 18 $457.99
20552 <1% 28 $381.16
J1010 Injection, methylprednisolone acetate, 1 mg <1% 27 $57.42
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 0% 140 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTROBRIDGE, ANDREW (OWNER)